This study found a significant association between higher serum anti-thyroperoxidase (anti-TPO) antibody levels and the occurrence of chronic spontaneous urticaria, suggesting that testing for anti-TPO antibodies alongside primary thyroid markers might be important in managing this condition.
April 2024 in “DAHUDER Medical journal” This study examined the relationship between thyroid autoimmunity and alopecia areata in patients aged 2-65 and found no statistically significant association, despite a notable correlation between anti-TPO levels and disease duration.
January 2022 in “Medical research archives” This article reviews the potential role of vitamin D supplementation as an adjunct to alemtuzumab therapy in multiple sclerosis management, noting its possible benefits for autoimmune comorbidities and patient adherence, but reports no new clinical results.
July 2025 in “Foundation University Journal of Dentistry” In this study, 25% of alopecia areata patients were found to have autoimmune disorders, with hypothyroidism being the most common, highlighting the importance of screening for autoimmune conditions, particularly thyroid disorders, in these patients.
6 citations
,
September 2024 in “Journal of Clinical Medicine” This review explored the relationship between autoimmune thyroiditis and various autoimmune skin conditions, highlighting shared genetic markers and immunological mechanisms, such as disrupted immune tolerance and oxidative stress, which may contribute to the development of these disorders.